Journal
NATURE REVIEWS NEUROLOGY
Volume 18, Issue 2, Pages 69-70Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41582-021-00606-5
Keywords
-
Categories
Funding
- Australian National Health and Medical Research Council Fellowship [APP1193826]
Ask authors/readers for more resources
Studies have shown that rare neurological complications are more common after SARS-CoV-2 infection than after COVID-19 vaccination. New approaches to risk-benefit analysis, such as Bayesian network models, can integrate global evidence and local factors to support decision-making and the global vaccination effort.
Rare neurological complications can occur after COVID-19 vaccination, but recent studies show that such complications are much more common after SARS-CoV-2 infection. Novel approaches to risk-benefit analysis such as Bayesian network models can integrate the latest global evidence with local factors to inform decision-making and support the global vaccination effort.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
